Free press releases distribution network?

Agency / Source: Akers Biosciences, Inc. (ABI)

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Akers Biosciences, Inc. Announced 2007 Annual Financial Results - ABI, manufacturer of rapid diagnostic products, announced that 2007 revenues totaled $5.5M, the highest in company history - AkersBiosciences.com
Akers Biosciences, Inc. Announced 2007 Annual Financial Results

 

PRZOOM - /newswire/ - Thorofare, NJ, United States, 2008/04/07 - ABI, manufacturer of rapid diagnostic products, announced that 2007 revenues totaled $5.5M, the highest in company history - AkersBiosciences.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Other highlights include the first positive EBITDA of $1.4M which represents ABI’s maiden positive operating cash flow.

Akers Biosciences, Inc. a leading designer and manufacturer of rapid diagnostic screening and testing products, announces its annual results for the year ended 31 December, 2007.

2007 Highlights:
· Revenues of $5.5 million (2006: $ 1.0 million) are the highest in the Company’s history
· First positive EBITDA of $1.4 million (2006: negative EBITDA of $7.8 million)
· Maiden positive cash flow from operations
· Significant orders from United States military departments received and shipped
· $4.5 million in fixed convertible debt financing completed during the period to enhance stability of capital structure
· Acquisition completed of ‘Bout Time Marketing, LLC, a distributor of breathalyzer product, providing a direct channel to the US Military for BreathScan ® resulting in increased margins.
· New distribution arrangement signed for Tier 1 status with Cardinal Health, a distributor to over 4,000 US hospitals, resulted in a significant increase in sales of the PIFA Heparin/Platelet Factor 4 Rapid Assay.

Thomas A. Nicolette, Chief Executive Officer of ABI, commented: “In early 2007 we set about to effect a bold and immediate transition. Our strategy has been to transform the significant investment in our patented platform technologies over the past decade into real value by establishing routes to markets of our core products leading to profitable revenue generation. In 2007 we achieved that with the highest sales in the Company’s history, its first positive EBITDA from operations and the establishment of significant recurring revenue streams. These are the foundation blocks upon which we intend to build our core product line sales both domestically and abroad and bring forward new and mass market potential products."

About Akers Biosciences, Inc. (ABI)

Akers Biosciences, Inc. (akersbiosciences.com) was founded in 1989, with the objective of developing proprietary, in vitro diagnostic technologies that accelerate the rate at which clinicians can obtain single-patient results. The tests and sample preparation devices that emerge from our rapid technology platforms are designed to provide the same level of accuracy as traditional laboratory testing methods, but at a fraction of the cost and turn-around time.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Akers Biosciences, Inc. (ABI)

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Akers Biosciences, Inc. Announced 2007 Annual Financial Results

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Patrice McMorrow - AkersBiosciences.com 
856-848-2116 pmcmorrow[.]akersbiosciences.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Akers Biosciences, Inc. (ABI) securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Akers Biosciences, Inc. (ABI) / Company Profile


Read Medical Services/Equipment Most Recent Related Press Releases:

PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit RightITnow Ltd

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today